Clinical Trial Update: Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating topical corticosteroids added to oral antivirals for preventing recurrence of HSV keratitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Keratitis

Snippet

Sponsor: NYU Langone Health | Conditions: Herpes Simplex Virus Keratitis | Phase 4 | Status: WITHDRAWN